| http://www.w3.org/ns/prov#value | - A further list and description of these risks, uncertainties and other factors can be ...Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences... guidelines issued by the U.S. Department of Health and Human Services list emtricitabine and tenofovir (the components of Truvada) in combination ... regulation
|
